cystamine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cormier, K; Del Signore, SJ; Ferrante, RJ; Ferro, JL; Goodrich, S; Hunt, BB; Kim, J; Matson, S; Matson, WR; Ryu, H; Smith, K; Stack, EC | 1 |
1 other study(ies) available for cystamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cystamine; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Mitochondrial Diseases; Neurotoxins; Oxidative Stress; Oxidopamine; Parkinson Disease | 2008 |